KG-548 is a small molecule research compound that functions as a dual inhibitor of ARNT/TACC3 and HIF-1alpha. It disrupts HIF-2 dimerization and coactivator binding, suppressing lactate production. This inhibitor is a valuable tool for investigating cancer metabolism and tumor hypoxia in both in vitro and in vivo models.
